Philips is investing more than $150 million toward U.S. manufacturing and research and development with the goal of expanding the production of AI-powered health technology innovations. While it's far ...

Merck & Co. will build a $3 billion pharmaceutical manufacturing facility in Elkton that is expected to create 500 jobs, Gov. Glenn Youngkin and the company announced at a ceremonial groundbreaking ...

Merck has kicked off construction of a new $3 billion facility at its sprawling manufacturing campus in Elkton, Virginia. The investment is part of the New Jersey company’s plan to spend more than $70 ...

Merck & Co. will build a $3 billion pharmaceutical manufacturing facility in Elkton, Va. The new site is expected to create 500 jobs, Virginia Gov. Glenn Youngkin and the company announced at a ...

Health technology company Philips is investing more than $150 million in manufacturing and research and development in the U.S. and is expanding manufacturing facilities in Pennsylvania and Minnesota.

An India-headquartered global biopharmaceutical company is making a big bet on the Garden State. Biocon Ltd. focuses on enhancing affordable access to complex therapies for chronic conditions, such as ...

The Department of Engineering Design and Manufacturing is involved in a variety of research and training activities. The following is an overview of the areas that research teams work in, with some ...

Seven weeks after opening a new $1 billion vaccine manufacturing facility in North Carolina, Merck has revealed that it is breaking ground on another $1 billion plant—this one in Wilmington, Delaware.

Biogen said it intends to invest an additional $2 billion over the next three years to expand operations at its largest manufacturing facilities within North Carolina’s Research Triangle Park (RTP).

TreisD will take over a manufacturing facility in Mascot. The company makes high-security three-dimensional film images. TreisD plans to hire locally for the jobs at its new facility. Atlanta ...

Another pharmaceutical giant is planning to spend billions on its U.S. footprint amid the Trump administration’s domestic manufacturing push. AstraZeneca intends to spend $50B on expansion across the ...